Basic Information
| LncRNA/CircRNA Name | SNHG20 |
| Synonyms | NA |
| Region | GRCh38_17:77086716-77094990 |
| Ensemble | ENSG00000234912 |
| Refseq | NR_027058 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | epithelial ovarian cancer |
| ICD-0-3 | C56.9 |
| Methods | qPCR, Western blot |
| Sample | EOC tissues,cell lines (IGROV-1, CAOV-3, A2780,OVCAR-3) |
| Expression Pattern | up-regulated |
| Function Description | Statistical analysis indicated that SNHG20 overexpression was positively correlated with poor histological grade and LN metastasis |
| Pubmed ID | 30846486 |
| Year | 2019 |
| Title | LncRNA SNHG20 predicts a poor prognosis and promotes cell progression in epithelial ovarian cancer. |
External Links
| Links for SNHG20 | GenBank HGNC NONCODE |
| Links for epithelial ovarian cancer | OMIM COSMIC |